The "death Diamond": Rapid thrombelastography identifies lethal hyperfibrinolysis

Journal of Trauma and Acute Care Surgery

Volumn 79, Issue 6, 2015, Pages 925-929

  Chapman, Michael P ^a,b,d   Moore, Ernest E ^a,b   Moore, Hunter B ^a,b   Gonzalez, Eduardo ^a,b   Morton, Alexander P ^a,b   Chandler, James ^a,b   Fleming, Courtney D ^a,b   Ghasabyan, Arsen ^a,b   Silliman, Christopher C ^a,c   Banerjee, Anirban ^a   Sauaia, Angela ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL COLORADO   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

hemorrhagic shock; Hyperfibrinolysis; mortality; thrombelastography; trauma induced coagulopathy

Indexed keywords

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; ERYTHROCYTE CONCENTRATE; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; INJURY SCALE; INTENSIVE CARE UNIT; LETHALITY; MAJOR CLINICAL STUDY; MORTALITY; PENETRATING TRAUMA; POSTINJURY HYPERFIBRINOLYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RESUSCITATION; THROMBOELASTOGRAPHY; BLOOD; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOLYSIS; INCIDENCE; INTENSIVE CARE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; REGISTER; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS;

ADULT; BLOOD COAGULATION DISORDERS; CRITICAL CARE; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOLYSIS; HUMANS; INCIDENCE; INJURY SEVERITY SCORE; MALE; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBELASTOGRAPHY;

EID: 84949091851     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000871     Document Type: Article

References (21)

1. Chapman MP, Moore EE, Ramos CR, Ghasabyan A, Harr JN, Chin TL, Stringham JR, Sauaia A, Silliman CC, Banerjee A,. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg. 2013; 75 (6): 961-967.
2. Cotton BA, Harvin JA, Kostousouv V, Minei KM, Radwan ZA, Schöchl H, Wade CE, Holcomb JB, Matijevic N,. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg. 2012; 73 (2): 365-370.
3. CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011; 377 (9771): 1096-1101,. 101.e1-101.e2.
4. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376 (9734): 23-32.
5. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ,. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study. Arch Surg. 2012; 147 (2): 113-119.
6. Cohen MJ, Call M, Nelson M, Calfee CS, Esmon CT, Brohi K, Pittet JF,. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg. 2012; 255 (2): 379-385.
7. Gonzalez E, Moore EE, Moore HB, Chapman MP, Silliman CC, Banerjee A,. Trauma-induced coagulopathy: an institution's 35 year perspective on practice and research. Scand J Surg. 2014; 103 (2): 89-103.
8. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, Mackway-Jones K, Parr MJ, Rizoli SB, Yukioka T, Hoyt DB, Bouillon B,. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008; 65 (4): 748-754.
9. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, Cox ED, Gehrke MJ, Beilman GJ, Schreiber M, Flaherty SF, Grathwohl KW, Spinella PC, Perkins JG, Beekley AC, McMullin NR, Park MS, Gonzalez EA, Wade CE, Dubick MA, Schwab CW, Moore FA, Champion HR, Hoyt DB, Hess JR,. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007; 62 (2): 307-310.
10. Jenkins DH, Rappold JF, Badloe JF, Berséus O, Blackbourne L, Brohi KH, Butler FK, Cap AP, Cohen MJ, Davenport R, DePasquale M, Doughty H, Glassberg E, Hervig T, Hooper TJ, Kozar R, Maegele M, Moore EE, Murdock A, Ness PM, Pati S, Rasmussen T, Sailliol A, Schreiber MA, Sunde GA, van de Watering LM, Ward KR, Weiskopf RB, White NJ, Strandenes G, Spinella PC,. Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: definitions, current practice, and knowledge gaps. Shock. 2014; 41 (Suppl 1): 3-12.
11. Kashuk JL, Moore EE, Sawyer M, Wohlauer M, Pezold M, Barnett C, Biffl WL, Burlew CC, Johnson JL, Sauaia A,. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010; 252 (3): 434-442.
12. Kutcher ME, Cripps MW, McCreery RC, Crane IM, Greenberg MD, Cachola LM, Redick BJ, Nelson MF, Cohen MJ,. Criteria for empiric treatment of hyperfibrinolysis after trauma. J Trauma Acute Care Surg. 2012; 73 (1): 87-93.
13. Hardaway RM,. The significance of coagulative and thrombotic changes after haemorrhage and injury. J Clin Pathol Suppl (R Coll Pathol). 1970; 4: 110-120.
14. Morton AP, Moore EE, Wohlauer MV, Lo K, Silliman CC, Burlew CC, Banerjee A,. Revisiting early postinjury mortality: are they bleeding because they are dying or dying because they are bleeding? J Surg Res. 2013; 179 (1): 5-9.
15. Blackbourne LH, Baer DG, Cestero RF, Inaba K, Rasmussen TE,. Exsanguination shock: the next frontier in prevention of battlefield mortality. J Trauma. 2011; 71 (Suppl 1): S1-S3.
16. Moore HB, Moore EE, Gonzalez E, Chapman MP, Chin TL, Silliman CC, Banerjee A, Sauaia A,. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Traumea Acute Care Surg. 2014; 77 (6): 811-817.
17. Cohen MJ,. Towards hemostatic resuscitation: the changing understanding of acute traumatic biology, massive bleeding, and damage-control resuscitation. Surg Clin North Am. 2012; 92 (4): 877-891. viii.
18. Johansson PI, Sørensen AM, Larsen CF, Windeløv NA, Stensballe J, Perner A, Rasmussen LS, Ostrowski SR,. Low hemorrhage-related mortality in trauma patients in a Level I trauma center employing transfusion packages and early thromboelastography-directed hemostatic resuscitation with plasma and platelets. Transfusion. 2013; 53 (12): 3088-3099.
19. Gando S, Tedo I, Kubota M,. Posttrauma coagulation and fibrinolysis. Crit Care Med. 1992; 20 (5): 594-600.
20. Hardaway RM,. The role of intravascular clotting in the etiology of shock. Ann Surg. 1962; 155: 325-338.
21. Hardaway RM, Brune WH, Geever EF, Burns JW, Mock HP,. Studies on the role of intravascular coagulation in irreversible hemorrhagic shock. Ann Surg. 1962; 155: 241-250.